Opposing effects by pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 778-784

  Ciranna, Lucia ^a   Cavallaro, Sebastiano ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Cyclic AMP; Hippocampus; Patch clamp; Synaptic transmission

Indexed keywords

8 BROMO CYCLIC AMP; ADENOSINE CYCLIC 3',5' HYDROGENPHOSPHOROTHIOATE; CALCIUM CHELATING AGENT; CYCLIC AMP DERIVATIVE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMPLITUDE MODULATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EVOKED RESPONSE; HIPPOCAMPUS; NERVE CELL PLASTICITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0842342526     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00300-5     Document Type: Article

References (31)

1. Acsady L., Arabadzisz D., Freund T.F. Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in rat hippocampus. Neuroscience. 73:1996;299-315.
2. Acsady L., Gorcs T.J., Freund T.F. Different populations of vasoactive intestinal polypeptide-immunoreactive interneurons are specialized to control pyramidal cells or interneurons in the hippocampus. Neuroscience. 73:1996;317-334.
3. Arimura A., Somogyvari-Vigh A., Miyata A., Mizuno K., Coy D.H., Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology. 129:1991;2787-2789.
4. Banke T.G., Bowie D., Lee H., Huganir R.L., Schousboe A., Traynelis S.F. Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J. Neurosci. 20:2000;89-102.
5. D'Agata V., Cavallaro S., Stivala F., Canonico P.L. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain. Eur. J. Neurosci. 8:1996;310-318.
6. Darvish N., Russell J.T. Neurotransmitter-induced novel modulation of a nonselective cation channel by a cAMP-dependent mechanism in rat pineal cells. J. Neurophysiol. 79:1998;2546-2556.
7. Fletcher W.H., Van Patten S.M., Cheng H.C., Walsh D.A. Cytochemical identification of the regulatory subunit of the cAMP-dependent protein kinase by use of fluorescently labeled catalytic subunit. Examination of protein kinase dissociation in hepatoma cells responding to 8-Br-cAMP stimulation. J. Biol. Chem. 261:1986;5504-5513.
8. Gereau R.W., Conn P.J. Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism. Neuron. 12:1994;1121-1129.
9. Haas H.L., Gahwiler B.H. Vasoactive intestinal polypeptide modulates neuronal excitability in hippocampal slices of the rat. Neuroscience. 47:1992;273-277.
10. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank S.A., Waschek J.A. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:1998;265-270.
11. Hessler N.A., Shirke A.M., Malinow R. The probability of transmitter release at a mammalian central synapse. Nature. 366:1993;569-572.
12. Jaworski D.M., Proctor M.D. Developmental regulation of pituitary adenylate cyclase-activating polypeptide and PAC(1) receptor mRNA expression in the rat central nervous system. Brain Res. Dev. Brain Res. 120:2000;27-39.
13. Kandel E., Abel T. Neuropeptides, adenylyl cyclase, and memory storage. Science. 268:1995;825-826.
14. Kondo T., Tominaga T., Ichikawa M., Iijima T. Differential alteration of hippocampal synaptic strength induced by pituitary adenylate cyclase activating polypeptide-38 (PACAP-38). Neurosci. Lett. 221:1997;189-192.
15. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:1989;567-574.
16. Otto C., Zuschratter W., Gass P., Schutz G. Presynaptic localization of the PACAP-type I-receptor in hippocampal and cerebellar mossy fibres. Brain Res. Mol. Brain Res. 66:1999;163-174.
17. Otto C., Kovalchuk Y., Wolfer D.P., Gass P., Martin M., Zuschratter W., Grone H.J., Kellendonk C., Tronche F., Maldonado R., Lipp H.P., Konnerth A., Schutz G. Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J. Neurosci. 21:2001;5520-5527.
18. Roberto M., Brunelli M. PACAP-38 enhances excitatory synaptic transmission in the rat hippocampal CA1 region. Learn. Mem. 7:2000;303-311.
19. Roberto M., Scuri R., Brunelli M. Differential effects of pacap-38 on synaptic responses in rat hippocampal ca1 region. Learn. Mem. 8:2001;265-271.
20. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 169:1970;1217-1218.
21. Shioda S., Shuto Y., Somogyvari-Vigh A., Legradi G., Onda H., Coy D.H., Nakajo S., Arimura A. Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci. Res. 28:1997;345-354.
22. Shioda S., Ozawa H., Dohi K., Mizushima H., Matsumoto K., Nakajo S., Takaki A., Zhou C.J., Nakai Y., Arimura A. PACAP protects hippocampal neurons against apoptosis: involvement of JNK/SAPK signaling pathway. Ann. N.Y. Acad. Sci. 865:1998;111-117.
23. Skoglosa Y., Takei N., Lindholm D. Distribution of pituitary adenylate cyclase activating polypeptide mRNA in the developing rat brain. Brain Res. Mol. Brain Res. 65:1999;1-13.
24. Skoglosa Y., Lewen A., Takei N., Hillered L., Lindholm D. Regulation of pituitary adenylate cyclase activating polypeptide and its receptor type 1 after traumatic brain injury: comparison with brain-derived neurotrophic factor and the induction of neuronal cell death. Neuroscience. 90:1999;235-247.
25. Soderling T.R., Derkach V.A. Postsynaptic protein phosphorylation and LTP. Trends Neurosci. 23:2000;75-80.
26. Uchida D., Arimura A., Somogyvari-Vigh A., Shioda S., Banks W.A. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res. 736:1996;280-286.
27. Van Haastert P.J., Van Driel R., Jastorff B., Baraniak J., Stec W.J., De Wit R.J. Competitive cAMP antagonists for cAMP-receptor proteins. J. Biol. Chem. 259:1984;10020-10024.
28. Wang H.L., Li A., Wu T. Vasoactive intestinal polypeptide enhances the GABAergic synaptic transmission in cultured hippocampal neurons. Brain Res. 746:1997;294-300.
29. 2+. Hippocampus. 10:2000;57-63.
30. Yanovsky Y., Sergeeva O.A., Freund T.F., Haas H.L. Activation of interneurons at the stratum oriens/alveus border suppresses excitatory transmission to apical dendrites in the CA1 area of the mouse hippocampus. Neuroscience. 77:1997;87-96.
31. Zucker R.S., Regehr W.G. Short-term synaptic plasticity. Annu. Rev. Physiol. 64:2002;355-405.